NASDAQ:OCUL

Ocular Therapeutix Stock Insider Trading

Healthcare > Biotechnology

Buy OCUL

*Your capital is at risk

$9.64

+0.170 (+1.80%)

At Close: Jul 02, 2026

Ocular Therapeutix Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 25.62. In total, the insiders bought 5.55M and sold 1.91M OCUL shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	25.62
● Buy	5.55M shares
● Sell	1.91M shares
53% Buy Activity Negligible or No Correlation
Sell Signal Low Confidence Feb 12, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 25.62. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 16, 2026 Buy	Common Stock G-Gift	Dugel Pravin See Remarks	Officer	50 092 Value: $447.8K
Jun 16, 2026 Sell	Common Stock G-Gift	Dugel Pravin See Remarks	Officer	50 092 Value: $0
Jun 10, 2026 Buy	Stock Option (Right to Buy) A-Award	Williams Leslie J. Director	Director	44 000 Value: $384.6K
Jun 10, 2026 Buy	Stock Option (Right to Buy) A-Award	Raines Merilee Director	Director	44 000 Value: $384.6K
Jun 10, 2026 Buy	Stock Option (Right to Buy) A-Award	Lindstrom Richard L Md Director	Director	44 000 Value: $384.6K
Jun 10, 2026 Buy	Stock Option (Right to Buy) A-Award	Hong Seung Suh Director	Director	44 000 Value: $384.6K
Jun 10, 2026 Buy	Stock Option (Right to Buy) A-Award	Robins Jason Shand Chief Financial Officer	C-Suite Officer	14 024 Value: $122.6K
Jun 10, 2026 Buy	Common Stock A-Award	Robins Jason Shand Chief Financial Officer	C-Suite Officer	15 441 Value: $135.0K
Jun 10, 2026 Buy	Common Stock A-Award	Warden Charles M Director	Director	14 000 Value: $122.4K
Jun 10, 2026 Buy	Stock Option (Right to Buy) A-Award	Warden Charles M Director	Director	44 000 Value: $384.6K
Jun 10, 2026 Buy	Common Stock A-Award	Graves Adrienne L Director	Director	14 000 Value: $122.4K
Jun 10, 2026 Buy	Stock Option (Right to Buy) A-Award	Graves Adrienne L Director	Director	44 000 Value: $384.6K
Jun 10, 2026 Buy	Common Stock A-Award	Hong Seung Suh Director	Director	14 000 Value: $122.4K
Jun 10, 2026 Buy	Common Stock A-Award	Lindstrom Richard L Md Director	Director	14 000 Value: $122.4K
Jun 10, 2026 Buy	Common Stock A-Award	Raines Merilee Director	Director	14 000 Value: $122.4K
Jun 10, 2026 Buy	Common Stock A-Award	Williams Leslie J. Director	Director	14 000 Value: $122.4K
Jun 03, 2026 Sell	Common Stock S-Sale	Waheed Nadia Chief Medical Officer	Officer	14 828 Value: $122.6K
May 28, 2026 Buy	Common Stock G-Gift	Dugel Pravin See Remarks	Officer	394 696 Value: $3.61M
May 28, 2026 Sell	Common Stock G-Gift	Dugel Pravin See Remarks	Officer	394 696 Value: $0
May 26, 2026 Sell	Common Stock S-Sale	Nayak Sanjay Chief Strategy Officer	Officer	1 858 Value: $15.2K
May 26, 2026 Sell	Common Stock S-Sale	Kaiser Peter Chief Development Officer	Officer	2 967 Value: $24.3K
May 26, 2026 Sell	Common Stock S-Sale	Dugel Pravin See Remarks	Officer	21 156 Value: $173.5K
May 26, 2026 Sell	Common Stock S-Sale	Heier Jeffrey S. Chief Scientific Officer	Officer	3 018 Value: $24.7K
Apr 09, 2026 Buy	Common Stock G-Gift	Dugel Pravin See Remarks	Officer	394 696 Value: $3.67M
Apr 09, 2026 Sell	Common Stock G-Gift	Dugel Pravin See Remarks	Officer	394 696 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT OCULAR THERAPEUTIX

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammati...

Read Full Profile Here